Eli Lilly threatens to cut 340B discounts for hospitals that won't share claims data, as the American Hospital Association calls the policy illegal.
Eli Lilly gives hospitals 5 days to comply with 340B claims data policy or lose discounts. The move signals regulatory pressure on pharma supply chain; providers must invest in governance to maintain negotiated pricing.
June 2, 2026 01:50 PM EDT
PharmaMarketing
Lilly gives hospitals deadline to comply with 340B claims data policy
Nicole DeFeudis
Eli Lilly is giving a group of hospitals five days to comply with its new claims data policy or risk losing their 340B discounts.
Eli Lilly's ultimatum to hospitals: Send 340B claims data by June 8 or lose discounts
Eli Lilly issues data sharing ultimatum to 340B hospitals
Eli Lilly warns hospitals to submit claims data in the next five days or lose their 340B drug discounts
Pharmalittle: We're reading about a Lilly threat to 340B hospitals, Ebola vaccine funding, and more
Lilly, Boehringer to slash at least $1B each from planned investments in Germany
This Data Platform Helps Healthcare Providers Walk The Line Between Privacy and Precision | AdExchanger
UnitedHealthcare to nix nearly two thirds of pediatric prior auths
Lilly, Ascidian link up in RNA exon editing pact
NewLimit’s $435M megaround; Lilly’s busy dealmaking week
Eli Lilly and Company said Monday evening that it will soon end 340B discount pricing for some of the hospitals that have not met…
Select hospitals have refused to share data to prove they’re not double-dipping drug discounts, Lilly said. Hospitals, which have…
Eli Lilly has told more than 1,000 hospitals participating in the 340B drug discount program to submit claims data over the next…
Lilly gave hospitals participating in a federal drug discount program five days to submit claims data or it will stop the price…
It’s been more than two years since Eli Lilly announced LillyDirect, a platform that combines telehealth and pharmacy services to…
Amgen is expanding its claims data requirements for pharmacies dispensing its drugs under the 340B federal drug discount program.
